Clinical Trial Update: Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC

View source ↗

Summary

Clinical trial update reporting completion of a study evaluating bevacizumab in combination with chemotherapy for advanced or recurrent non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University of Athens | Conditions: Non-small Cell Lung Cancer, Unresectable Malignant Neoplasm | Status: COMPLETED